Use of CELOX™ PPH in 98 cases of severe postpartum haemorrhage–a multicenter registry analysis.
Von Beckerath AK, Maul H, Gebauer G, Abdel-Kawi AF, Rolf N, Saade G, Bader W, Kusnierczak D, Berger R, Kienast C, Kienemund J, Schmid B. Am J Obstet Gynecol. 2016; 214(1 Suppl 1):S269. [poster presentation]
Multicentre registry analysis study (n=98)
- Assessment of the potential side effects of CELOX™ PPH, and to assess if the use of CELOX™ PPH reduces the rate of postpartum hysterectomies
- Women with PPH were treated in accordance to guidelines with the addition of uterine packing using CELOX™ PPH
- After the introduction of CELOX™ PPH the rate of postpartum hysterectomies reduced from 0.18% to 0.05% (p=0.0183)
- No adverse events were observed or reported
- CELOX™ PPH is cost-effective and easy to use